代谢功能障碍相关的肥胖性肝病中的生物标志物
Arka De1, Naga Chalasani2, Ajay Duseja1
1Department of Hepatology, Postgraduate Institute of Medical Education and Research, Sector 12, Chandigarh 160012, India.
与代谢功能障碍相关的脂肪性肝病 (MASLD) 是一个日益严重的全球健康问题. 本综述探讨了用于诊断和管理MASLD的非侵入性血液和成像生物标志物,为肝脏活检提供了替代方案.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 生物标志物发现发现
- 诊断成像 诊断成像 诊断成像
背景情况:
- 与代谢功能障碍相关的脂肪性肝病 (MASLD) 是全球慢性肝病的主要原因.
- MASLD的进展可能导致严重的结局,如肝硬化和肝细胞癌.
- 目前的诊断方法,包括肝活检,具有显著的局限性.
研究的目的:
- 对MASLD的血液和成像生物标志物的实用性进行全面审查.
- 讨论它们在诊断,分期,预后和管理中的作用.
- 突出肝脏活检的非侵入性替代方案.
主要方法:
- 对MASLD基于血液的生物标志物研究的文献综述.
- 对用于MASLD评估的成像技术的研究进行分析.
- 综合关于诊断和预后中的生物标志物表现的证据.
主要成果:
- 各种血液检查显示,在检测肝脏脂肪和炎症方面有前途.
- 像超声波和MRI这样的成像模式为MASLD的严重程度提供了宝贵的见解.
- 生物标志物可以帮助风险分层和监测治疗反应.
结论:
- 非侵入性生物标志物对于应对MASLD流行病至关重要.
- 基于血液和成像的标记物为肝脏活检提供了可行的替代方案.
- 需要进一步的研究来验证和在临床实践中实施这些工具.
更多相关视频
06:26Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis
Published on: July 18, 2025
09:27Analysis of Liver Microenvironment During Early Progression of Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in Zebrafish
Published on: April 1, 2021
相关概念视频
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
What is Metabolism?
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Liver Histology
Hepatocytes perform a variety of essential functions. They secrete...
